Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid Tumors

NEXT STORY
Clinical Trial Begins to Evaluate Physiological Effects of a Saturated Fat Found in Milk
PREV STORY
OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ayala Pharmaceuticals to Present at Jefferies London Healthcare Conference

author_avatar
NASDAQ Market News

Sorrento Therapeutics Mexico to Partner with the World Boxing Council for the Screening of COVID-19 of all Convention Attendees with COVI-STIX at the 59th World Boxing Council Convention in Mexico City

author_avatar
NASDAQ Market News

Shire plc : Block listing Interim Review

BLOCK LISTING SIX MONTHLY RETURN May 23, 2018 - Shire plc (LSE: SHP, NASDAQ: ...

author_avatar
NASDAQ Market News